The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo
about
The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice.Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infectionPotential uses of probiotics in clinical practiceProbiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseasesCharacterization of reutericyclin produced by Lactobacillus reuteri LTH2584Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucinsLactobacillus acidophilus (strain LB) from the resident adult human gastrointestinal microflora exerts activity against brush border damage promoted by a diarrhoeagenic Escherichia coli in human enterocyte-like cells.Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model.Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells.The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens.Lactobacillus johnsonii ameliorates intestinal, extra-intestinal and systemic pro-inflammatory immune responses following murine Campylobacter jejuni infectionAntagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LBE. coli Nissle 1917 Affects Salmonella adhesion to porcine intestinal epithelial cellsHost specific diversity in Lactobacillus johnsonii as evidenced by a major chromosomal inversion and phage resistance mechanismsIn vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics.Inhibition of Giardia intestinalis by extracellular factors from Lactobacilli: an in vitro study.A Lactobacillus acidophilus strain of human gastrointestinal microbiota origin elicits killing of enterovirulent Salmonella enterica Serovar Typhimurium by triggering lethal bacterial membrane damage.pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium.Fermented dairy products modulate Citrobacter rodentium-induced colonic hyperplasia.Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens.Peptides and proteins with antimicrobial activity.Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements.Probiotic potential of lactic acid bacteria present in home made curd in southern IndiaProbiotics affect virulence-related gene expression in Escherichia coli O157:H7The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiotaProbiotic properties of Lactobacillus strains isolated from Tibetan kefir grains.The gastrointestinal microbiome: a malleable, third genome of mammals.Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity.Examination of bacterial inhibition using a catalytic DNAPre-treatment with Bifidobacterium breve UCC2003 modulates Citrobacter rodentium-induced colonic inflammation and organ specificity.Immunomodulation of Lactobacillus rhamnosus GG (LGG)-derived soluble factors on antigen-presenting cells of healthy blood donors.Proposed model: mechanisms of immunomodulation induced by probiotic bacteria.Antagonistic activity of Lactobacillus isolates against Salmonella typhi in vitro.The social structure of microbial community involved in colonization resistance.Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agentsAmelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment.Probiotics and the Gut Immune System: Indirect Regulation.
P2860
Q22066391-527AF058-C233-4265-8738-285C6EF310F6Q24535026-435785EF-58AF-499B-B5BC-6A37E2B9932AQ24669669-8353C3D2-CF35-4FC0-8CEF-8AA266A56D2CQ24681377-70385A29-2C4E-4452-98B0-C6651300140FQ26800020-16AD8CAA-C175-456E-A37C-C2017C9D79C8Q28139925-B9248378-204C-4047-9E87-E32A5497629AQ28910480-11259206-E0D8-466B-8E6E-7265E63A38DCQ32109047-67C5D5BC-89E9-4B9E-AAD9-FEE8EB166A5EQ33410248-C2065069-C334-4281-A6BD-B18030DA8892Q33554139-7FEC0F6E-1E67-4795-B5CD-633DEE58DE5BQ33639134-2E4590A0-843C-4BF7-870D-EA66265F89FCQ33650357-7E1568EA-BC2A-4299-BC43-F983839C75E4Q33651733-E7977A17-8EEC-4DA9-945E-FE772DEF2A34Q33705072-D33F7729-CA2A-4512-9F16-C23A535054FBQ33719312-AF27269C-7286-4E55-8B8F-3A12AB17DE89Q33838402-ED1CEF88-27F3-4A0C-9242-CFECF53630F4Q33886266-E241AB7A-A7C5-4451-A1D4-84671EDC9753Q33983372-B2D34AFD-A77D-4FC2-91CC-FA3F6BE68D05Q33990613-E06DC62C-7520-4030-AB9F-9B509A65E453Q34097875-7A9DA235-619D-47BF-998B-D102EDF3466DQ34098013-99CCA6EF-9442-4A79-AF82-EF8E9EBCBFDEQ34149331-4942CAF2-DD87-4506-B624-B33611915935Q34238001-55640457-69AF-4C88-B2BE-5B6C4FF54CA3Q34501382-E0872996-07E8-4A47-9255-B5AD7CB35AC9Q34559453-D526D510-ED30-4380-9CD9-F664F9D998F2Q34590806-E32D35C2-0217-4907-9BE1-004D4478CB7DQ34627560-9C7788D0-3C06-4C26-B179-1ACBDC59615FQ34647328-257E43C6-C018-409D-8B0A-A3DFA0759FCCQ34874755-DFE93443-BC0D-4764-BC81-D0CD5D6694F0Q35214930-C1C3AD8C-CC12-4C68-B34F-B99767727121Q35361878-33402B63-B547-4CE9-A136-1555BC817169Q35532061-180BE769-5659-4C5E-8CC1-E6BFA5443036Q36523130-C8773F73-2F83-4D5A-8E44-CFBF6EF25B10Q36670816-57F7DE1A-0E47-4E60-BD34-3C0CB55BBC45Q36759892-48545C43-4ADD-4897-AE0F-444BDA6052DCQ37245012-6CB02727-3A16-495D-B7A0-6D82D455F7C8Q37595150-8F877561-A03A-4F86-9335-F28459CE1EDDQ37712802-5ED93312-CAE1-4E8A-9CDF-EA06D2ECC87EQ37748061-ABCDBCF9-F076-4B5D-A2BB-117C0F159672Q38598371-D6A54FEC-39A7-4EB6-98BC-9902577DF0AD
P2860
The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The human Lactobacillus acidop ...... s) active in vitro and in vivo
@ast
The human Lactobacillus acidop ...... s) active in vitro and in vivo
@en
type
label
The human Lactobacillus acidop ...... s) active in vitro and in vivo
@ast
The human Lactobacillus acidop ...... s) active in vitro and in vivo
@en
prefLabel
The human Lactobacillus acidop ...... s) active in vitro and in vivo
@ast
The human Lactobacillus acidop ...... s) active in vitro and in vivo
@en
P2093
P2860
P1476
The human Lactobacillus acidop ...... s) active in vitro and in vivo
@en
P2093
Bernet-Camard MF
Brassart D
P2860
P304
P407
P577
1997-07-01T00:00:00Z